Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus
Amrita K Cheema,1 Prabhjit Kaur,1 Amina Fadel,2 Noura Younes,3 Mahmoud Zirie,4 Nasser M Rizk2,5 1Department of Oncology, Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, DC, USA; 2Biomedical Sciences Department, College of Health Sciences and Biomedical Resea...
Enregistré dans:
Auteurs principaux: | Cheema AK, Kaur P, Fadel A, Younes N, Zirie M, Rizk NM |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/113f03c14d3041c29cee9687f2d39e47 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
par: Tafere GG, et autres
Publié: (2020) -
Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
par: Badawi A
Publié: (2010) -
Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus
par: Lingxiao Wang, et autres
Publié: (2021) -
Novel biomarkers for prediabetes, diabetes, and associated complications
par: Dorcely B, et autres
Publié: (2017) -
Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland
par: Huber CA, et autres
Publié: (2014)